Abstract
ABSTRACT
Neisseria meningitidis and Neisseria gonorrhoeae, two highly related species that might have emerged from a common commensal ancestor, constitute major human threats. Vaccines are available to prevent N. meningitidis infection, whereas there are only a limited number of antibiotics available for N. gonorrhoeae. Unfortunately, some strains of these species are rapidly evolving and capable of escaping human interventions. Thus, it is now urgent to develop new avenues to fight these bacteria. This study reports that a boron-based salt, sodium tetraphenylborate (NaBPh4), displays high bactericidal activity and remarkable specificity against N. meningitidis and N. gonorrhoeae. Other closely related commensal species such as Neisseria lactamica, which is found in the normal flora of healthy individuals, were found to be less affected even at 5-fold higher doses of NaBPh4. This specificity was further observed when much lower sensitivity was found for more distant Neisseriaceae species (such as Neisseria elongata or Kingella oralis) and completely unrelated species. Significant boron uptake by N. meningitidis cells was observed after incubation with 5 μM NaBPh4, as measured by inductively coupled plasma mass spectrometry, suggesting that this drug candidate’s target(s) could be located intracellularly or within the cell envelope. Furthermore, mutants with slightly decreased susceptibility displayed alterations in genes coding for cell envelope elements, which reduced their virulence in an animal model of infection. Finally, a single dose of NaBPh4 resulted in a significant reduction in bacterial burden in a mouse model of N. meningitidis bacteremia. Although numerous boron-containing species were previously reported for their complex biological activities, the observation of this narrow selectivity is unprecedented and of potential importance from a therapeutic standpoint.
Funder
Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada
Gouvernement du Canada | Canadian Institutes of Health Research
Fonds de Recherche du Québec - Santé
Agence Universitaire de la Francophonie
Réseau Québécois de Recherche sur les Médicaments
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference39 articles.
1. High throughput ANI analysis of 90K prokaryotic genomes reveals clear species boundaries;Jain;Nat Commun,2018
2. Pathogenesis of meningococcemia;Coureuil;Cold Spring Harb Perspect Med,2013
3. 3. World Health Organization. 2016. WHO guidelines for the treatment of Neisseria gonorrhoeae. World Health Organization, Geneva, Switzerland.
4. Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development;Dretler;Hum Vaccin Immunother,2018
5. Meningococcal vaccines: WHO position paper, November 2011;Wkly Epidemiol Rec,2011
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献